The OncoImmunin® High Throughput Screening (HTS) system is now available for
licensing. The system utilizes OncoImmunin's patented cell permeable fluorogenic substrate
design for molecular analysis of enzymatic activities, including proteases such as caspases-1,
3/7, 6, 8, and 9, beta-secretase, and matrix metalloproteases (MMPs), inside
and on the surfaces of live cells in
96-, 384-, or 1536-well plate formats.
Our capabilities can be specifically tailored to meet the unique needs of
each client. Through its development, research, and consulting services, OncoImmunin® can also design, synthesize, and produce probes for
clients for molecular analyses of protease, nuclease, glycosidase,
and lipase activities in live cells. Please contact the Company for details regarding
these OncoImmunin® services.